|
Market Research Report
U.S. Inherited Disease Molecular Diagnostics Markets
| Published by |
Frost & Sullivan |
| Published |
July, 2010 |
Product code |
125351 |
| Content info |
60 Pages |
| Price |
|
|
U.S. Inherited Disease Molecular Diagnostics Markets published by Frost & Sullivan in July, 2010. This report consists of 60 Pages and the price starts from US $ 6000.
Abstract
This research service analyzes the market for the inherited disease molecular
diagnostics markets. FDA-cleared genetic tests for CF and inherited
thrombophilia are included. Key market drivers and restraints are ranked and
discussed. Key technology and trends that will impact the market are
identified. Revenue forecasts, a market share analysis, and a product analysis
are also provided. The competitive structure is provided for cystic fibrosis
test vendors, inherited thrombophilia test vendors, and laboratories that
offer of cystic fibrosis testing. The major market challenges are outlined
along with strategic recommendations to address them.
Table of Contents
1. Executive Summary
Market Overview
2. Total Inherited Disease Molecular Diagnostics Market
Market Overview
- Introduction
- Scope and Segmentation
- Research Methodology
- Market Engineering Measurements
Market Challenges and Strategic Recommendations
- Industry Challenges
- Strategic Recommendations
Market Drivers and Restraints
- Market Drivers
- Market Restraints
Technology and Market Trends
- Technology and Market Trends
Market Forecasts and Competitive Analysis
- Revenue Forecasts
- Competitive Structure - Cystic Fibrosis Test Vendors
- Competitive Structure - Cystic Fibrosis Test Services
- Competitive Structure - Inherited Thrombophilia Test Vendors
- Market Share Analysis - Cystic Fibrosis Test Vendors
- Market Share Analysis - Inherited Thrombophilia Test Vendors
- Product Analysis - Inherited Disease Molecular Diagnostics Tests and
Platforms
- Product Analysis - Cystic Fibrosis Tests
- Product Analysis - Inherited Thrombophilia Tests
|
